Friday morning October 31, nanoHUB tools and home directories will be unavailable from 6 AM to noon (eastern time); we're getting a new file server! All tool sessions will be lost. Also, the web site will be unavailable for about 15 minutes sometime between 8-9 AM.

Support

Support Options

Submit a Support Ticket

 

Tags: nanomedicine

Description

Nanomedicine is the medical application of nanotechnology. Nanomedicine ranges from the medical applications of nanomaterials, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology. Current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials. More information on Nanomedicine can be found here.

Resources (81-100 of 157)

  1. Ethics of Stem Cells and Therapeutic Cloning

    27 Nov 2007 | Online Presentations | Contributor(s): James Leary

    Invited lecture for Purdue University course SOC 573

    http://nanohub.org/resources/3578

  2. BME 695N Lecture 19: In vivo model systems to study nanomedical approaches to cancer detection and intervention

    27 Nov 2007 | Online Presentations | Contributor(s): Deborah W Knapp

    With Deborah Knapp as guest lecturer.

    http://nanohub.org/resources/3521

  3. BME 695N Lecture 21: FDA and EPA Regulatory Issues

    27 Nov 2007 | Online Presentations | Contributor(s): James Leary

    Outline: Introduction and overview How does the FDA think about nanomedical systems? The 2006 Nanotechnology Task Force Some details of the Nanotechnology Task Force...

    http://nanohub.org/resources/3549

  4. Engineering Nanomedical Systems

    16 Nov 2007 | Online Presentations | Contributor(s): James Leary

    This tutorial will cover general problems and approaches to the design of engineered nanomedical systems. An example to be covered is the engineering design of programmable multilayered...

    http://nanohub.org/resources/3539

  5. BME 695N Lecture 20: GMP and issues of quality control manufacture of nanodelivery systems

    15 Nov 2007 | Online Presentations | Contributor(s): James Leary

    Outline: Overview What does cGMP mean? Why GMP? Controlling processes means more predictable outcomes… Enforcement What can be learned from the semi-conductor...

    http://nanohub.org/resources/3529

  6. BME 695N Lecture 18: Designing nanodelivery systems for in-vivo use

    12 Nov 2007 | Online Presentations | Contributor(s): James Leary

    Outline: Overview – the in-vitro to ex-vivo to in-vivo paradigm In-vitro - importance of choosing suitable cell lines Ex-vivo – adding the complexity of in-vivo background while...

    http://nanohub.org/resources/3515

  7. BME 695N Lecture 17: Assessing nanotoxicity at the single cell level

    06 Nov 2007 | Online Presentations | Contributor(s): James Leary

    Outline: Outline – the need for single cell measures of nanotoxicity There is more than one way for a cell to die... Necrosis" vs. "Apoptosis" There are other forms of...

    http://nanohub.org/resources/3497

  8. BME 695N Lecture 16: Assessing drug efficacy at the single cell level

    02 Nov 2007 | Online Presentations | Contributor(s): James Leary

    Outline: Introduction and overview Nanomedical treatment at the single cell level requires evaluation at the single cell level For evaluation purposes, does structure reveal function? The...

    http://nanohub.org/resources/3478

  9. BME 695N Lecture 15: Nanodelivery of therapeutic genes & molecular biosensor feedback control systems

    30 Oct 2007 | Online Presentations | Contributor(s): James Leary

    Outline: Introduction and overview Some of the advantages of therapeutic genes Some of the advantages of molecular biosensor feedback control systems Why a nanodelivery approach is...

    http://nanohub.org/resources/3472

  10. BME 695N Lecture 14: Challenges of proper drug dosing with nanodelivery systems

    29 Oct 2007 | Online Presentations | Contributor(s): James Leary

    Outline: Overview of drug dosing problem Problems of scaling up doses from animal systems Basing dosing on size, area, weight of recipient Vast differences between adults in terms of genetics,...

    http://nanohub.org/resources/3466

  11. BME 695N Lecture 13: Assessing Zeta Potentials

    29 Oct 2007 | Online Presentations | Contributor(s): James Leary

    Outline: Introduction – the importance of the zeta potential Nanoparticle-nanoparticle interactions Nanoparticle-cell interactions Part of the initial nanomedical system-cell targeting...

    http://nanohub.org/resources/3418

  12. KIST/PU Multiplex Detection of Cell Surface Markers Using Plasmonic Sensors

    23 Oct 2007 | Online Presentations | Contributor(s): Joseph M K Irudayaraj

    Gold nanorod molecular probes (GNrMPs) were designed and fabricated for multiplex identification of cell surface markers in HBECs. Cells were probed directly using dark field microscopy integrated...

    http://nanohub.org/resources/3408

  13. KIST/PU Design and Performance of Bioresponsive Nanocarriers with Tunable Reactivity for Drug and Gene Delivery

    23 Oct 2007 | Online Presentations | Contributor(s): Dave Thompson

    Our lab has focused on the development of bioresponsive nanocarriers that are designed to release their cargo upon entry into acidic environments such as those found in cellular endosomes and...

    http://nanohub.org/resources/3391

  14. KIST/PU Bridging Nonlinear Optical Imaging and Nanotechnology with Medicine

    23 Oct 2007 | Online Presentations | Contributor(s): Ji-Xin Cheng

    Our interdisciplinary research develops and utilizes state-of-the-art optical imaging techniques and nanotechnology to tackle compelling biomedical problems highly related to human health....

    http://nanohub.org/resources/3396

  15. KIST/PU Multi-Component, Multi-Functional Nanomedical Systems for Drug/Gene Delivery

    23 Oct 2007 | Online Presentations | Contributor(s): James Leary

    In this brief paper we describe some of our recent efforts to construct multi-component, multi-functional nanomedical systems for delivery of therapeutic genes. We first describe the general...

    http://nanohub.org/resources/3380

  16. KIST/PU Tumor-Homing Chitosan-Based Nanoparticles for Cancer Theragnosis; Imaging, Drug Delivery and Therapy

    23 Oct 2007 | Online Presentations | Contributor(s): Ick Chan Kwon

    We have prepared self-assembled polymeric drug carriers containing fluorophore and loaded drugs for theragnostic imaging of tumors. This new type of polymeric drug carriers visualizes the...

    http://nanohub.org/resources/3401

  17. KIST/PU Introduction to Global Research Laboratory (GRL) Program: Molecular Imaging and Nanomedicine for Theragnosis using Nano-Bio Materials

    23 Oct 2007 | Online Presentations | Contributor(s): Kui Won Choi

    The Global Research Laboratory (GRL) program was initiated by the Korea Foundation for International Cooperation of Science and Technology (KICOS) in 2006. The GRL program has been designed to...

    http://nanohub.org/resources/3386

  18. BME 695N Lecture 12: Introduction to X-ray Photoelectron Spectroscopy and the Examples of Biologically-Relevant Applications

    19 Oct 2007 | Online Presentations | Contributor(s): Dmitry Zemlyanov

    With Dmitry Zemlyanov as guest lecturer.

    http://nanohub.org/resources/3413

  19. BME 695N Lecture 11: Construction of biomolecule conjugated nanoparticles

    30 Sep 2007 | Online Presentations | Contributor(s): Don Bergstrom

    With Donald E. Bergstrom as guest lecturer.

    http://nanohub.org/resources/3331

  20. BME 695N Lecture 9: Atomic Force Microscopy (AFM) for Nanomedical Systems (cells and nanoparticles)

    30 Sep 2007 | Online Presentations | Contributor(s): Helen McNally

    What Helen McNally as guest lecturer.

    http://nanohub.org/resources/3278

nanoHUB.org, a resource for nanoscience and nanotechnology, is supported by the National Science Foundation and other funding agencies. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the National Science Foundation.